{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-045747","form_type":"8-K","ticker":"MPT","cik":"0001287865","company_name":"MEDICAL PROPERTIES TRUST INC","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.234667+00:00","generated_at":"2026-06-19T01:57:05.416075+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MPT reports Q4 net loss of $0.24 per share; $171M impairment on Prospect properties","bullets":["Q4 2022 net loss of ($0.24) per diluted share; full-year net income $1.50 per share, up 35% YoY.","NFFO per share $0.43 in Q4 and $1.82 for full year, up 4% YoY.","Includes $171M real estate impairment and $112M write-off of unbilled rent related to Prospect Medical Holdings.","Acquired six Priory behavioral health facilities in UK for £233M; expects ~$50M additional cash rent from escalators in 2023.","Introduced 2023 guidance: net income per share $0.83-$0.98; NFFO per share $1.50-$1.65."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-045747","json":"https://secwatch.observer/filing/0001193125-23-045747.json","markdown":"https://secwatch.observer/filing/0001193125-23-045747.md","text":"https://secwatch.observer/filing/0001193125-23-045747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523045747/0001193125-23-045747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523045747/d457057d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T01:57:05.416075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4162ac18ca06a7de87c0472b4e19bd3e21d282d2","claim":"MEDICAL PROPERTIES TRUST INC reported the fourth quarter ended December 31, 2022 results: net income ($140) million, EPS ($0.24) per diluted share. Guidance initiated.","evidence_excerpt":"Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523045747/0001193125-23-045747-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Net income","value":"($140) million"},{"label":"EPS","value":"($0.24) per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d0d0a7e66c945db9dfd29102698b9a2ea450cd96","claim":"MEDICAL PROPERTIES TRUST INC reported the full-year ended December 31, 2022 results: net income $903 million, EPS $1.50 per diluted share. Guidance initiated.","evidence_excerpt":"Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523045747/0001193125-23-045747-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full-year ended December 31, 2022"},{"label":"Net income","value":"$903 million"},{"label":"EPS","value":"$1.50 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}